Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Anterix's Asset Writedowns and Impairment history spans 5 years, with the latest figure at $127000.0 for Q1 2022.

  • For Q1 2022, Asset Writedowns and Impairment rose 182.22% year-over-year to $127000.0; the TTM value through Dec 2021 reached -$82000.0, down 254.72%, while the annual FY2021 figure was $85000.0, 84.78% up from the prior year.
  • Asset Writedowns and Impairment reached $127000.0 in Q1 2022 per ATEX's latest filing, up from -$254000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $534000.0 in Q2 2018 to a low of -$254000.0 in Q4 2021.
  • Average Asset Writedowns and Impairment over 5 years is $70307.7, with a median of $33000.0 recorded in 2019.
  • The largest YoY upside for Asset Writedowns and Impairment was 246.15% in 2021 against a maximum downside of 2409.09% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $200000.0 in 2018, then tumbled by 83.5% to $33000.0 in 2019, then crashed by 66.67% to $11000.0 in 2020, then plummeted by 2409.09% to -$254000.0 in 2021, then surged by 150.0% to $127000.0 in 2022.
  • Per Business Quant, the three most recent readings for ATEX's Asset Writedowns and Impairment are $127000.0 (Q1 2022), -$254000.0 (Q4 2021), and $112000.0 (Q3 2021).